SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 11, 2001, Pages 3356-3365

A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix

(10) Follen, M a Atkinson, E N a Schottenfeld, D a Malpica, A a West, L a Lippman, S a Zou, C a Hittelman, W N a Lotan, R a Waun Ki Hong, a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENRETINIDE; PLACEBO; RETINOIC ACID;

ADULT; ALOPECIA; ANISOCORIA; ANOREXIA; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; NAUSEA; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ANTINEOPLASTIC AGENTS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHEILITIS; CROSS-OVER STUDIES; EXANTHEMA; FEMALE; FENRETINIDE; HUMANS; MEDICAL FUTILITY; PATIENT COMPLIANCE; PHOTOSENSITIVITY DISORDERS; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0035185164 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (64)

References (17)

1
- 0029689121
- Chemoprevention of breast cancer with fenretinide
- (1996) IARC Sci. Publ. , vol.136 , pp. 87-94
- Veronesi, U.¹ De Palo, G.² Costa, A.³ Formelli, F.⁴ Decensi, A.⁵

2
- 0018778594
- N-(4-hydroxyphenyl) retinamide, a new retinoid for prevention of breast cancer in the rat
- (1979) Cancer Res. , vol.39 , pp. 1339-1346
- Moon, R.C.¹ Thompson, H.J.² Becci, P.J.³ Grubbs, C.J.⁴ Gander, R.J.⁵ Newton, D.L.⁶ Smith, J.M.⁷ Phillips, S.L.⁸ Henderson, W.R.⁹ Muller, L.T.¹⁰ Brown, C.C.¹¹ Sporn, M.B.¹²

3
- 0021918978
- Lack of genotoxicity of the cancer chemopreventive agent N-(4-hydroxyphenyl) retinamide
- (1995) Fundam. Appl. Toxicol. , vol.5 , pp. 144-150
- Paulson, J.D.¹ Oldham, J.W.² Preston, R.F.³ Newman, D.⁴

4
- 0029816269
- Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β-glucuronide
- (1996) FASEB J. , vol.10 , pp. 1014-1024
- Formelli, F.¹ Barua, A.B.² Olson, J.A.³

5
- 0030322859
- New agents for cancer chemoprevention
- (1996) J. Cell. Biochem. , vol.26 S , pp. 1-28
- Kelloff, G.J.¹ Boone, C.W.² Crowell, J.A.³ Steele, V.E.⁴ Lubet, R.A.⁵ Doody, L.A.⁶ Malone, W.F.⁷ Hawk, E.T.⁸ Sigman, C.C.⁹

6
- 0001319804
- Retinoids and human cancer
- M. B. Sporn, A. B. Roberts, D. S. Goodman (eds.), Ed. 2. New York: Raven Press
- (1994) The Retinoids , pp. 597
- Hong, W.K.¹ Itri, L.M.²

7
- 0027395951
- Comparison of low-dose isotretinoin with β carotene to prevent oral carcinogenesis
- (1993) N. Engl. J. Med. , vol.328 , pp. 15-20
- Lippman, S.M.¹ Batsakis, J.G.² Toth, B.B.³ Weber, R.S.⁴ Lee, J.J.⁵ Martin, J.W.⁶ Hays, G.L.⁷ Goepfert, H.⁸ Hong, W.K.⁹

8
- 0023188916
- Retinoids as preventive and therapeutic anticancer agents
- (1987) Cancer Treat. Rep. , vol.71 , pp. 391-405
- Lippman, S.M.¹ Kessler, J.F.² Meyskens F.L., Jr.³

9
- 0025091456
- Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
- (1990) N. Engl. J. Med. , vol.323 , pp. 795-801
- Hong, W.K.¹ Lippman, S.M.² Itri, L.M.³ Karp, D.D.⁴ Lee, J.S.⁵ Byers, R.M.⁶ Schantz, S.P.⁷ Kramer, A.M.⁸ Lotan, R.⁹ Peters, L.J.¹⁰

10
- 0030744057
- Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
- (1997) J. Natl. Cancer Inst. (Bethesda) , vol.89 , pp. 1191-1198
- Oridate, N.¹ Suzuki, S.² Higuchi, M.³ Mitchell, M.F.⁴ Hong, W.K.⁵ Lotan, R.⁶

11
- 0030842351
- N-(4-hydroxyphenyl) retinamide activation of a distinct pathway signaling apoptosis
- (1997) J. Natl. Cancer Inst. (Bethesda) , vol.89 , pp. 1179-1181
- Dmitrovsky, E.¹

12
- 0033563006
- Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms
- (1999) Cancer Res. , vol.59 , pp. 2493-2498
- Sun, S.Y.¹ Li, W.² Yue, P.³ Lippman, S.M.⁴ Hong, W.K.⁵ Lotan, R.⁶

13
- 0026582421
- Power calculations for likelihood ratio tests in generalized linear models
- (1992) Biometrics , vol.48 , pp. 31-39
- Self, S.G.¹ Mauritsen, R.H.² Ohara, J.³

14
- 0033520713
- Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
- (1999) J. Natl. Cancer Inst. (Bethesda) , vol.91 , pp. 1847-1856
- Veronesi, U.¹ De Palo, G.² Marubini, E.³ Costa, A.⁴ Formelli, F.⁵ Mariani, L.⁶ Decensi, A.⁷ Camerini, T.⁸ Del Turco, M.R.⁹ Di Mauro, M.G.¹⁰ Muraca, M.G.¹¹ Del Vecchio, M.¹² Pinto, C.¹³ D'Aiuto, G.¹⁴ Boni, C.¹⁵ Campa, T.¹⁶ Magni, A.¹⁷ Micheli, R.¹⁸ Perloff, M.¹⁹ Malone, W.F.²⁰ Sporn, M.B.²¹ more..

15
- 0033875561
- N-(hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of bronchial epithelium
- (2000) Clin. Cancer Res. , vol.6 , pp. 2973-2979
- Kurie, J.M.¹ Lee, J.S.² Khuri, F.R.³ Mao, L.⁴ Morice, J.C.⁵ Lee, J.J.⁶ Walsh, G.L.⁷ Broxson, A.⁸ Lippman, S.M.⁹ Ro, J.Y.¹⁰ Kemp, B.L.¹¹ Liu, D.¹² Fritsche, H.A.¹³ Xu, X.¹⁴ Lotan, R.¹⁵ Hong, W.K.¹⁶

16
- 12244294577
- Conversion factors
- Ed. 9. Stanford, CT: Appleton & Lange
- (1999) Handbook of Clinical Drug Data , pp. 1009
- Anderson, P.O.¹ Knoben, J.E.² Troutman, W.G.³

17
- 0027360292
- Five-year administration of fenretinide: Pharmacokinetics and effects on plasma retinol concentrations
- (1993) J. Clin. Oncol. , vol.11 , pp. 2036-2042
- Formelli, F.¹ Clerici, M.² Campa, T.³ Di Mauro, M.G.⁴ Magni, A.⁵ Mascotti, G.⁶ Moglia, D.⁷ De Palo, G.⁸ Costa, A.⁹ Veronesi, U.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.